WASHINGTON, March 13 -- Food and Drug Administration has issued a notice called: Medical Devices With Indications Associated With Weight Loss-Premarket Considerations; Guidance for Industry and Food and Drug Administration Staff; Availability.
The notice was published in the Federal Register on March 13 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Medical Devices with Indications Associated with Weight Loss-Premarket Considerations." This guidance document provides recommendations regarding non-clinical testing and clinical study design for medical devices with indications fo...